Vericel Corp [VCEL] stock prices are up 2.62% to $37.2 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The VCEL shares have gain 6.65% over the last week, with a monthly amount glided 12.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vericel Corp [NASDAQ: VCEL] stock has seen the most recent analyst activity on September 17, 2025, when BTIG Research downgraded its rating to a Neutral. Previously, Canaccord Genuity started tracking the stock with Buy rating on August 09, 2024, and set its price target to $57. On June 20, 2024, TD Cowen initiated with a Buy rating and assigned a price target of $55 on the stock. Truist upgraded its rating to a Buy and increased its price target to $51 on January 25, 2024. BTIG Research upgraded its rating to a Buy but $39 remained the price target by the analyst firm on August 08, 2023. BTIG Research downgraded its rating to Neutral for this stock on November 10, 2022. In a note dated November 09, 2022, Truist downgraded a Hold rating on this stock.
The stock price of Vericel Corp [VCEL] has been fluctuating between $29.24 and $63.00 over the past year. Currently, Wall Street analysts expect the stock to reach $41 within the next 12 months. Vericel Corp [NASDAQ: VCEL] shares were valued at $37.2 at the most recent close of the market. An investor can expect a potential return of 10.22% based on the average VCEL price forecast.
Analyzing the VCEL fundamentals
The Vericel Corp [NASDAQ:VCEL] reported sales of 249.12M for trailing twelve months, representing a surge of 20.09%. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.02 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.01 points at the first support level, and at 34.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.83, and for the 2nd resistance point, it is at 38.45.
Ratios To Look Out For
It’s worth pointing out that Vericel Corp [NASDAQ:VCEL]’s Current Ratio is 4.97. Further, the Quick Ratio stands at 4.56, while the Cash Ratio is 1.96. Considering the valuation of this stock, the price to sales ratio is 7.53, the price to book ratio is 6.12 and price to earnings (TTM) ratio is 298.32.
Transactions by insiders
Recent insider trading involved Hopper Jonathan Mark, Chief Medical Officer, that happened on Sep 02 ’25 when 10000.0 shares were sold. Officer, Hopper Jonathan Mark completed a deal on Sep 02 ’25 to buy 10000.0 shares. Meanwhile, Director MCLAUGHLIN KEVIN F sold 7000.0 shares on Aug 06 ’25.
